These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6871796)

  • 1. Plasma concentrations of trifluoperazine following single low doses.
    Midha KK; Hawes EM; McKay G; Hubbard JW; Korchinski ED; Keegan DL
    Can Med Assoc J; 1983 Aug; 129(4):324. PubMed ID: 6871796
    [No Abstract]   [Full Text] [Related]  

  • 2. A gas chromatographic mass spectrometric assay for plasma trifluoperazine concentrations following single doses.
    Midha KK; Roscoe RM; Hall K; Hawes EM; Cooper JK; McKay G; Shetty HU
    Biomed Mass Spectrom; 1982 May; 9(5):186-90. PubMed ID: 7093440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma-trifluoperazine concentrations during high dose therapy.
    Curry SH; Stewart RB; Springer PK; Pope JE
    Lancet; 1981 Feb; 1(8216):395-6. PubMed ID: 6110036
    [No Abstract]   [Full Text] [Related]  

  • 4. GLC analysis of trifluoperazine in human plasma.
    Javaid JI; Dekirmenjian H; Davis JM
    J Pharm Sci; 1982 Jan; 71(1):63-6. PubMed ID: 7057382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive gas chromatographic determination of trifluoperazine in human plasma.
    Gillespie TJ; Sipes IG
    J Chromatogr; 1981 Apr; 223(1):95-102. PubMed ID: 7251779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High doses of chlorpromazine and trifluoperazine in the treatment of patients suffering from schizophrenia.
    Bagadia VN; Shastri PC; Dave KP; Shah LP
    J Postgrad Med; 1971 Jan; 17(1):2-9. PubMed ID: 5553769
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of plasma trifluoperazine by gas chromatography and selected ion monitoring.
    Whelpton R; Curry SH; Watkins GM
    J Chromatogr; 1982 Mar; 228():321-6. PubMed ID: 7076755
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind comparison of the acridane derivative, clomacran phosphate and trifluoperazine in schizophrenia.
    Angus JW; Deutsch LJ; Edwards JG; Simpson GM
    Behav Neuropsychiatry; 1969 Apr; 1(1):13-8. PubMed ID: 4920977
    [No Abstract]   [Full Text] [Related]  

  • 9. High dosage trifluoperazine in schizophrenia. Comparison of the efficacy of high and usual doses of trifluoperazine in the treatment of chronic schizophrenics.
    Carscallen HB; Rochman H; Lovegrove TD
    Can Psychiatr Assoc J; 1968 Oct; 13(5):459-61. PubMed ID: 5685522
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug management in chronic schizophrenia.
    Tune LE; McHugh PR; Coyle JT
    Johns Hopkins Med J; 1982 Jan; 150(1):45-8. PubMed ID: 7054584
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of generalized edema in patient with schizophrenia.
    Holmes IH; Forrest A
    Can Med Assoc J; 1978 Nov; 119(10):1169. PubMed ID: 743656
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioimmunoassay for the sulfoxide metabolite of trifluoperazine and its application to a kinetic study in humans.
    Aravagiri M; Hawes EM; Midha KK
    J Pharm Sci; 1984 Oct; 73(10):1383-7. PubMed ID: 6502485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult-onset stuttering as a presenting feature of schizophrenia: restoration of fluency with trifluoperazine.
    Menkes DB; Ungvari GS
    J Nerv Ment Dis; 1993 Jan; 181(1):64-5. PubMed ID: 8419519
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of cholesterol in the distribution of haloperidol and trifluoperazine in blood and plasma.
    Rice E; Makuku S
    Biochem Pharmacol; 1981 May; 30(9):951-7. PubMed ID: 7236316
    [No Abstract]   [Full Text] [Related]  

  • 15. The schizophrenic's individual response to trifluoperazine.
    Knopp W; Van Sickle J; Delzell B; Body L
    Curr Ther Res Clin Exp; 1967 Feb; 9(2):51-9. PubMed ID: 4962531
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacologic characteristics of triftazin syrup].
    Tolmacheva NS; Blinkova NF; Shcherbakova OV; Shmar'ian MI; Parin VV
    Farmakol Toksikol; 1978; 41(6):680-3. PubMed ID: 720579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study.
    Gendron A; Sirois G; Nair NP; Bloom D; Movin-Osswald G; Uppfeldt G
    J Psychiatry Neurosci; 1995 Jul; 20(4):287-96. PubMed ID: 7647082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium citrate syrup and trifluoperazine hydrochloride concentrate incompatibility: effect on serum lithium levels.
    McGee JL; Alexander B; Perry PJ
    Am J Hosp Pharm; 1980 Aug; 37(8):1052. PubMed ID: 7405933
    [No Abstract]   [Full Text] [Related]  

  • 19. [The dynamics of the mesodiencephalic component of nuclear and periodic schizophrenia during Stelazine therapy].
    Shmilovich LA; Fukel'man RI; Rykova RG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(10):1524-9. PubMed ID: 6000315
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioimmunoassay for fluphenazine in human plasma.
    Midha KK; Cooper JK; Hubbard JW
    Commun Psychopharmacol; 1980; 4(2):107-14. PubMed ID: 7428331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.